R. Minami et al., STEREOSELECTIVE ANALYSIS OF THE DISPOSITION OF TOSUFLOXACIN ENANTIOMERS IN MAN, European Journal of Clinical Pharmacology, 45(5), 1993, pp. 489-491
The pharmacokinetics of tosufloxacin enantiomers after oral administra
tion of racemic tosufloxacin were examined in healthy volunteers. Only
small differences were observed in time to peak concentration (2.6 +/
- 0.3 [mean +/- SEM] h for (+)-tosufloxacin vs 2.4 +/- 0.2 h for (-)-t
osufloxacin), elimination half-life (3.61 +/- 0.24 h vs 3.49 +/- 0.23
h), and area under the curve (2.78 +/- 0.19 h . mug/ml vs 2.87 +/- 0.1
9 h . mug/ml); however, peak concentration (0.40 +/- 0.03 mug/ml vs 0.
44 +/- 0.03 mug/ml), renal clearance (226 +/- 10 ml/min vs 202 +/- 10
ml/min), and urinary recovery (35.4 +/- 2.2 % vs 32.4 +/- 1.9 %) diffe
red significantly between enantiomers.